HGH Fragment 176-191 — 12.5 mg (5 vials × 2.5 mg)

HGH Fragment 176-191 — selective lipolytic peptide
5 lyophilised vials × 2.5 mg (total 12.5 mg)

• Targeted fat-loss: fragment 176-191 triggers lipolysis without raising blood sugar or IGF-1.
• Reconstitution: add 1 ml bacteriostatic water → 2.5 mg/ml; swirl gently, do not shake.
• Storage: refrigerate 2 – 8 °C after mixing; freeze-dried powder ships safely at room temp.
• Sample research dosing: 250 – 500 µg sub-Q 1–3× daily, 30 min pre-cardio, for 4 – 6 weeks.
• QC: ≥ 99 % purity (HPLC); endotoxin < 0.03 EU/mg; box with scratch-code authenticity.
• Cold-chain packed · tamper-evident vials · discreet, tracked worldwide delivery.